US Patent 7875703 LIR-9, a novel leukocyte immunoglobulin-like receptor

Patent 7875703 was granted and assigned to Immunex on January, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Immunex

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

78757030

Patent Inventor Names

Luis G. Borges0

Dirk M. Anderson0

Date of Patent

January 25, 2011

Patent Application Number

119819470

Date Filed

October 31, 2007

Patent Primary Examiner

‌

Michail A Belyavskyi

Patent abstract

A new family of immunoreceptor molecules of the immunoglobulin superfamily, (LIR) polypeptides is described. Disclosed are sequences encoding LIR family members and their deduced amino acid sequences, polypeptides encoded by DNA that hybridizes to defined nucleotide sequences, processes for producing polypeptides of the LIR family, and specific antibodies directed against LIR polypeptides. LIR family members can be used to treat autoimmune diseases and disease states associated with suppressed immune function.